The changing epidemiology of invasive fungal infections

DA Enoch, H Yang, SH Aliyu, C Micallef - Human fungal pathogen …, 2017 - Springer
Invasive fungal infections (IFI) are an emerging problem worldwide with invasive candidiasis
and candidemia responsible for the majority of cases. This is predominantly driven by the …

Colonization by Pneumocystis jirovecii and its role in disease

A Morris, KA Norris - Clinical microbiology reviews, 2012 - Am Soc Microbiol
Although the incidence of Pneumocystis pneumonia (PCP) has decreased since the
introduction of combination antiretroviral therapy, it remains an important cause of disease in …

Update on the diagnosis and treatment of Pneumocystis pneumonia

EM Carmona, AH Limper - Therapeutic advances in …, 2011 - journals.sagepub.com
Pneumocystis is an opportunistic fungal pathogen that causes an often-lethal pneumonia in
immunocompromised hosts. Although the organism was discovered in the early 1900s, the …

[HTML][HTML] Pneumocystis pneumonia suspected cases in 604 non-HIV and HIV patients

AL Bienvenu, K Traore, I Plekhanova… - International Journal of …, 2016 - Elsevier
Background Pneumocystis pneumonia (PCP) is one of the most devastating fungal diseases
in patients with impaired immunity. Effective antiviral therapies have reduced the burden of …

Failure of non-invasive ventilation in patients with acute lung injury: observational cohort study

S Rana, H Jenad, PC Gay, CF Buck, RD Hubmayr… - Critical Care, 2006 - Springer
Introduction The role of non-invasive positive pressure ventilation (NIPPV) in the treatment of
acute lung injury (ALI) is controversial. We sought to assess the outcome of ALI that was …

The hyper IgM syndromes: Epidemiology, pathogenesis, clinical manifestations, diagnosis and management

R Yazdani, S Fekrvand, S Shahkarami, G Azizi… - Clinical …, 2019 - Elsevier
Abstract Hyper Immunoglobulin M syndrome (HIGM) is a rare primary immunodeficiency
disorder characterized by low or absent levels of serum IgG, IgA, IgE and normal or …

Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection

X Monnet, E Vidal-Petiot, D Osman, O Hamzaoui… - Critical Care, 2008 - Springer
Background Little is known about the most severe forms of Pneumocystis jiroveci
pneumonia (PCP) in HIV-negative as compared with HIV-positive patients. Improved …

Outcome and prognostic factors of Pneumocystis jirovecii pneumonia in immunocompromised adults: a prospective observational study

BJ Gaborit, B Tessoulin, RA Lavergne, F Morio… - Annals of intensive …, 2019 - Springer
Background Pneumocystis jirovecii pneumonia (PJP) remains a severe disease associated
with high rates of invasive mechanical ventilation (MV) and mortality. The objectives of this …

Risk Factors of Mortality From Pneumocystis Pneumonia in Non-HIV Patients: A Meta-Analysis

Y Wang, X Zhou, M Saimi, X Huang, T Sun… - Frontiers in public …, 2021 - frontiersin.org
Background: We performed a meta-analysis to systematically review the risk factors of
mortality from non-HIV-related Pneumocystis pneumonia (PcP) and provide the theoretical …

Pneumocystis jiroveci pneumonia in patients with rheumatoid arthritis treated with infliximab: A retrospective review and case–control study of 21 patients

Y Komano, M Harigai, R Koike… - Arthritis Care & …, 2009 - Wiley Online Library
Objective To establish proper management of Pneumocystis jiroveci pneumonia (PCP) in
rheumatoid arthritis (RA) patients treated with infliximab. PCP has been observed in 0.4% of …